Microneedle Drug Delivery Systems Market Size, Share & Trends Analysis Report By Type (Solid, Hollow), By Material (Silicon, Metal), By Application (Dermatology, Drug Delivery), By Region, And Segment Forecasts, 2023 - 2030

Microneedle Drug Delivery Systems Market Size, Share & Trends Analysis Report By Type (Solid, Hollow), By Material (Silicon, Metal), By Application (Dermatology, Drug Delivery), By Region, And Segment Forecasts, 2023 - 2030


Microneedle Drug Delivery Systems Market Growth & Trends


The global microneedle drug delivery systems market size is expected to reach USD 9.46 billion by 2030, registering a CAGR of 7.4% from 2023 to 2030, according to a new report by Grand View Research, Inc. Growing demand for safer alternatives to conventional hypodermic injection and increasing awareness about minimally invasive and pain-free administration of drugs is expected to boost the market growth for microneedle drug delivery systems. Furthermore, increasing cases of diabetes are also expected to boost the market growth. For instance, as per the estimates of the World Health Organization (WHO) in 2021, approximately 463 million adults were living with diabetes, worldwide, representing 9.3% of the global population.

Microneedles offer several advantages over traditional drug delivery methods, such as oral or transdermal routes. Studies have shown that drug delivery by microneedles can improve drug absorption, bioavailability and efficacy, especially for drugs with poor water solubility or low permeability. For instance, a study published in "Journal of Controlled Release" showed that transdermal delivery of insulin using microneedles was more effective than subcutaneous injection.

The COVID-19 pandemic had a significant impact on drug delivery by microneedles. The major impact of the pandemic on the market was the increased demand for vaccine delivery. Microneedles have been explored as a potential delivery method for the COVID-19 vaccines due to their ease of use, low cost, and potential to induce a strong immune response. The pandemic has accelerated development of the microneedle-based vaccine delivery systems, with several companies and academic institutions working on COVID-19 vaccine patches.

However, the pandemic has also disrupted global supply chains, which has affected the production and distribution of microneedle-based drug delivery systems. Some manufacturers have faced challenges in obtaining raw materials and components, which has resulted in supply shortages and increased prices.

Microneedle Drug Delivery Systems Market Report Highlights

  • The hollow microneedle segment accounted for the largest revenue share in 2022, since they are considered ideal for the use of vaccine and hormonal therapy patients
  • Dissolving microneedle segment is expected to grow at the fastest rate during the forecast period, as it only requires one step, the microneedle needs not be removed after insertion
  • The metal material segment accounted for the highest revenue share in 2022; stainless steel and titanium are the most frequently employed metals
  • By application, drug delivery segment dominated the market in 2022
  • The vaccine segment is expected to experience the fastest growth rate during the forecast period due to the increased awareness of vaccination among populations
  • Asia Pacific is anticipated to grow at the fastest CAGR during the forecast period due to the presence of untapped opportunities in the emerging economies of China and India
Please note The report will be delivered in 3-8 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Material
1.1.3. Application
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1.1. Commodity flow analysis (Model 1)
1.6.1.2. Approach 1: Commodity flow approach
1.6.1.3. Volume price analysis (Model 2)
1.6.1.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Material outlook
2.2.3. Application outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Microneedle Drug Delivery Systems Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. The increasing demand for safer substitute to conventional hypodermic injections
3.4.1.2. Increase in diabetic cases across the globe
3.4.1.3. Technological advancements
3.4.2. Market restraint analysis
3.4.2.1. Limited number of approved products
3.4.2.2. Complications/risks associated with microneedles
3.5. Microneedle Drug Delivery Systems Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. Microneedle Drug Delivery Systems : Type Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Solid
4.1.2. Hollow
4.1.3. Dissolving
4.1.4. Coated
4.1.5. Others
4.2. Type Market Share, 2022 & 2030
4.3. Segment Dashboard
4.4. Global Microneedle Drug Delivery Systems Market by Type Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Solid
4.5.1.1. Solid market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Hollow
4.5.2.1. Hollow market estimates and forecast 2018 to 2030 (USD Million)
4.5.3. Dissolving
4.5.3.1. Dissolving market estimates and forecast 2018 to 2030 (USD Million)
4.5.4. Coated
4.5.4.1. Coated market estimates and forecast 2018 to 2030 (USD Million)
4.5.5. Others
4.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Microneedle Drug Delivery Systems : Material Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Silicon
5.1.2. Metal
5.1.3. Polymer
5.1.4. Others
5.2. Material Market Share, 2022 & 2030
5.3. Segment Dashboard
5.4. Global Microneedle Drug Delivery Systems Market by Material Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Silicon
5.5.1.1. Silicon market estimates and forecast 2018 to 2030 (USD Million)
5.5.2. Metal
5.5.2.1. Metal market estimates and forecast 2018 to 2030 (USD Million)
5.5.3. Polymer
5.5.3.1. Polymer market estimates and forecast 2018 to 2030 (USD Million)
5.5.4. Others
5.5.4.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Microneedle Drug Delivery Systems : Application Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Dermatology
6.1.2. Drug delivery
6.1.3. Pain management
6.1.4. Cancer therapy
6.1.5. Vaccine delivery
6.1.6. Others
6.2. Application Market Share, 2022 & 2030
6.3. Segment Dashboard
6.4. Global Microneedle Drug Delivery Systems Market by Application Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030for the following
6.5.1. Dermatology
6.5.1.1. Dermatology market estimates and forecast 2018 to 2030 (USD Million)
6.5.2. Hormone delivery
6.5.2.1. Hormone delivery market estimates and forecast 2018 to 2030 (USD Million)
6.5.3. Pain management
6.5.3.1. Pain management market estimates and forecast 2018 to 2030 (USD Million)
6.5.4. Cancer therapy
6.5.4.1. Cancer therapy market estimates and forecast 2018 to 2030 (USD Million)
6.5.5. Vaccine delivery
6.5.5.1. Vaccine delivery market estimates and forecast 2018 to 2030 (USD Million)
6.5.6. Others
6.5.6.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Microneedle Drug Delivery Systems Market: Regional Estimates & Trend Analysis
7.1. Regional market share analysis, 2022 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2021
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East and Africa
7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030
7.7. North America
7.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.7.2. U.S.
7.7.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.7.3. Canada
7.7.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.8. Europe
7.8.1. UK
7.8.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.8.2. Germany
7.8.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.8.3. France
7.8.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.8.4. Italy
7.8.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.8.5. Spain
7.8.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.8.6. Sweden
7.8.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.8.7. Norway
7.8.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.8.8. Denmark
7.8.8.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.9. Asia Pacific
7.9.1. China
7.9.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.9.2. Japan
7.9.2.1. Market estimates and forecast, 2018 - 2030 (Volume, Thousand)
7.9.3. India
7.9.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.9.4. Australia
7.9.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.9.5. Thailand
7.9.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.9.6. South Korea
7.9.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.10. Latin America
7.10.1. Brazil
7.10.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.10.2. Mexico
7.10.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.10.3. Argentina
7.10.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.11. MEA
7.11.1. Saudi Arabia
7.11.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.11.2. South Africa
7.11.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.11.3. UAE
7.11.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.11.4. Kuwait
7.11.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2021
8.3.4. Raphas
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Novartis International AG
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Becton, Dickinson and Company
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. B. Braun
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Nanopass technologies limited
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Termo
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Smiths Medical
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Cardinal Health
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. 3M
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings